AQR Capital Management
ANAC

AQR Capital Management’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

AQR Capital Management’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-33,431
Closed -$1.79M – 2361
2016
Q1 		$1.79M Buy
33,431
+2,498
+8% +$184K ﹤0.01% 1306
2015
Q4 		$3.5M Buy
30,933
+9,821
+47% +$1.08M 0.01% 1023
2015
Q3 		$2.48M Buy
21,112
+1,757
+9% +$229K 0.01% 1048
2015
Q2 		$1.5M Sell
19,355
-15,975
-45% -$1.05M ﹤0.01% 1319
2015
Q1 		$2.04M Sell
35,330
-4,700
-12% -$200K ﹤0.01% 1097
2014
Q4 		$1.29M Sell
40,030
-6,600
-14% -$198K ﹤0.01% 1536
2014
Q3 		$1.14M Sell
46,630
-20,500
-31% -$417K ﹤0.01% 1548
2014
Q2 		$1.19M Buy
67,130
+5,500
+9% +$88.5K ﹤0.01% 1570
2014
Q1 		$1.23M Buy
61,630
+12,500
+25% +$242K ﹤0.01% 1588
2013
Q4 		$824K Buy
+49,130
New +$680K ﹤0.01% 1818

Other funds holding ANAC

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

AQR Capital Management's ANAC Position: Q2 2016 in Review

AQR Capital Management sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 33,431 shares — an estimated $1.79M sold.

AQR Capital Management first reported a position in ANAC in Q4 2013 and held it in 10 quarters. The position peaked at $3.5M in Q4 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

  • AQR Capital Management reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
  • AQR Capital Management sold 33,431 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $1.79M.
  • AQR Capital Management first reported a position in ANACOR PHARMACEUTICALS INC COM in Q4 2013 and held it in 10 quarters.
  • AQR Capital Management's ANACOR PHARMACEUTICALS INC COM position peaked at $3.5M in Q4 2015.
  • 2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on AQR Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.